United States· US:70518-3965_3bb3e30f-210c-291c-e063-6294a90a280b

Doxazosin

A doxazosin product containing doxazosin, registered in United States by REMEDYREPACK INC.. The same ATC class is registered in 13 of our 19 countries.

ATC C02CA04Orange BookUS label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedDoxazosinATCC02CA04REGISTER NO.US:70518-3965_3bb3e30…PACKS LISTED2CHECKEDSeptember 12, 2026

Where it is registered

Doxazosin is registered in 13 of 19 countries.

Countries holding a registration under ATC C02CA04 (doxazosin), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 8 of them publish a price we can compare per daily dose

Doxazosin · ATC C02CA04

13 / 19 countries

  • Canada
  • Czechiaprice
  • Denmark
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Switzerlandprice
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of doxazosin costs, country by country.

Normalised to the WHO defined daily dose (4 mg), the median price runs from $0.35 in Italy to $0.59 in Switzerland — a ×1.7 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Doxazosin · price per daily dose (4 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$0.59
  • IT Italy$0.35
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
Doxazosin
Manufacturer
REMEDYREPACK INC.
Country
United States (US)
ATC code
C02CA04
ATC class
Doxazosin
Defined daily dose
4 mg, O
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 12, 2026

Packs & prices · 2

  • ndc11
    7051839650
    30 TABLET in 1 BLISTER PACK (70518-3965-0)
  • ndc11
    7051839651
    90 TABLET in 1 BOTTLE, PLASTIC (70518-3965-1)

Regulatory notes

UNII (FDA substance ID)
86P6PQK0MU
DOXAZOSIN MESYLATE
RxCUI 39173
Orange Book
A208719
ABABABAB
DailyMed SPL labels
1 version tracked

Interactions

259 interactions on record for doxazosin.

Graded by severity as the source publishes them — 85 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Doxazosin · interactions on record

259 records

  • 85 moderate
  • 173 info

Most severe, free to view

  • ThiethylperazinA04AB03moderate
  • DiphenhydraminA04AB05moderate
  • DronabinolA04AD10moderate
  • NabiloneA04AD11moderate

1 more interaction with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Doxazosin in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All doxazosin products

Authorised across Europe · EMA

The same active substance is authorised in 27 EEA countries. Names it is sold under:

  • Austria · Ascalan, Doxazosin 1a Pharma
  • Bulgaria · Доксазосин Чайкафарма, Зоксон
  • Cyprus · Cardura, Magurol
  • Czechia · Doxazosin G.L. Pharma, Kamiren
  • Germany · Cardular, Cardular Pp
  • Denmark · Cardosin Retard, Carduran Retard
  • Estonia · Cardura, Cardura Xl
  • Spain · Carduran Neo, Doxazosina Alter
  • France · Doxazosine L.P. Viatris, Doxazosine Lp Arrow
  • United Kingdom (Northern Ireland) · Cardura, Cardura Xl
  • Greece · Cardura, Maguran
  • Croatia · Doxa, Doxazin
  • Hungary · Cardura, Cardura Xl
  • Ireland · Cardura, Cardura Xl
  • Iceland · Cardosin Retard, Carduran Retard
  • Italy · Benur, Cardura
  • Lithuania · Cardura, Cardura Xl
  • Latvia · Cardura, Cardura Xl
  • Malta · Cardura, Doxatan
  • Netherlands · Cardura Xl, Doxazosin Syri Pharma
  • Norway · Carduran Cr
  • Poland · Adadox, Apo-Doxan
  • Portugal · Cardura Gits, Doxazosina Generis
  • Romania · Cardura Xl, Doxazosin Arena
  • Sweden · Alfadil, Alfadil Bph
  • Slovenia · Cardura Xl, Kamiren
  • Slovakia · Kamiren Xl

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/3a45b4c2-cff8-4903-bf93-8b061e74b5bd
GET /v1/drugs/3a45b4c2-cff8-4903-bf93-8b061e74b5bd?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unii": {
    "unii": "86P6PQK0MU",
    "rxcui": "39173",
    "inchikey": "VJECBOKJABCYMF-UHFFFAOYSA-N",
    "display_name": "DOXAZOSIN MESYLATE",
    "substance_type": "chemical",
    "ingredient_type": "INGREDIENT SUBSTANCE"
  },
  "route": "ORAL",
  "livertox": {
    "summary": null,
    "livertox_id": null,
    "hepatotoxicity_score": 5
  },
  "spl_meta": {
    "2ea9bb6b-a4f0-496a-b27b-4454167a4b70": {
      "match": "brand_token",
      "title": "DOXAZOSIN TABLET [PD-RX PHARMACEUTICALS, INC.]",
      "spl_version": "21",
      "published_date": "2026-05-15"
    }
  },
  "productid": "70518-3965_3bb3e30f-210c-291c-e063-6294a90a280b",
  "productndc": "70518-3965",
  "dosage_form": "TABLET",
  "orange_book": {
    "appl_no": "208719",
    "products": [
      {
        "rs": false,
        "rld": false,
        "te_code": "AB",
        "strength": "EQ 1MG BASE",
        "product_no": "001",
        "approval_date": "Jul 7, 2017"
      },
      {
        "rs": false,
        "rld": false,
        "te_code": "AB",
        "strength": "EQ 2MG BASE",
        "product_no": "002",
        "approval_date": "Jul 7, 2017"
      },
      {
        "rs": false,
        "rld": false,
        "te_code": "AB",
        "strength": "EQ 4MG BASE",
        "product_no": "003",
        "approval_date": "Jul 7, 2017"
      },
      {
        "rs": false,
        "rld": false,
        "te_code": "AB",
        "strength": "EQ 8MG BASE",
        "product_no": "004",
        "approval_date": "Jul 7, 2017"
      }
    ],
    "appl_type": "A"
  },
  "dea_schedule": null,
  "product_type": "HUMAN PRESCRIPTION DRUG",
  "substance_name": "DOXAZOSIN MESYLATE",
  "proprietary_name": "Doxazosin",
  "active_ingred_unit": "mg/1",
  "application_number": "ANDA208719",
  "marketing_category": "ANDA",
  "nonproprietary_name": "Doxazosin",
  "start_marketing_date": "20231217",
  "active_numerator_strength": "2"
}

See everything about doxazosin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.